Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-04

FDA Approved: OXYMORPHONE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved Epic Pharma's supplemental application for oxymorphone hydrochloride, authorizing the generic product as an analgesic for pain management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxymorphone hydrochloride (Oxymorphone hydrochloride)

Snippet

SUPPL AP for OXYMORPHONE HYDROCHLORIDE (OXYMORPHONE HYDROCHLORIDE)